European LeukemiaNet registry programme for low/INT-1 IPSS score myelodysplastic syndromes

被引：0
|
作者：
Bowen, D. [1 ]
Droste, J. [2 ]
Smith, A. [3 ]
Fenaux, P. [4 ]
Symeonidis, A. [5 ]
Sanz, G. [6 ]
Hellstrom-Lindberg, E. [7 ]
Cermak, J. [8 ]
Gologan, R. [9 ]
Germing, U. [10 ]
Stauder, R. [11 ]
Malcovati, L. [12 ]
de Witte, T. [2 ]
机构：
[1] Leeds Teaching Hosp, Leeds, W Yorkshire, England
[2] Univ Nijmegen, Nijmegen, Netherlands
[3] Univ York, York YO10 5DD, N Yorkshire, England
[4] Hop Avicenne, F-93009 Bobigny, France
[5] Univ Patras, GR-26110 Patras, Greece
[6] Hosp Univ La Fe, Valencia, Spain
[7] Karolinska Inst, Stockholm, Sweden
[8] Charles Univ Prague, Prague, Czech Republic
[9] Fundeni Clin Inst, Bucharest, Romania
[10] Univ Dusseldorf, Dusseldorf, Germany
[11] Innsbruck Med Univ, Innsbruck, Austria
[12] Univ Pavia, I-27100 Pavia, Italy
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70095-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S66 / S67
页数：2
相关论文
共 50 条
  • [41] A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS)
    Sabile, Jean M. G.
    Kaempf, Andy
    Tomic, Kaitlyn
    Manu, Gurusidda P. P.
    Swords, Ronan
    Migdady, Yazan
    LEUKEMIA & LYMPHOMA, 2023, 64 (10) : 1689 - 1694
  • [42] Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: Results of a prospective, randomized trial
    Oliva, E. N.
    Santini, V.
    Zini, G.
    Palumbo, G. A.
    Poloni, A.
    Cortelezzi, A.
    Rodeghiero, F.
    Voso, M. T.
    Molteni, A.
    Sanpaolo, G.
    Liberati, M.
    Morabito, F.
    Balleari, E.
    Impera, S.
    Salvi, F.
    Spiriti, M. A. Aloe
    Marino, A.
    Roda, F.
    Alati, C.
    Ronco, F.
    Di Raimondo, F.
    Leoni, P.
    Alimena, G.
    Latagliata, R.
    Nobile, F.
    LEUKEMIA RESEARCH, 2013, 37 : S162 - S162
  • [43] ELTROMBOPAG FOR THE TREATMENT OF THROMBOCYTOPENIA OF LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A PROSPECTIVE, RANDOMIZED, TRIAL
    Oliva, E.
    Santini, V.
    Zini, G.
    Palumbo, G.
    Poloni, A.
    Cortelezzi, A.
    Rodeghiero, F.
    Voso, M.
    Molteni, A.
    Sanpaolo, G.
    Liberati, A.
    Morabito, F.
    Balleari, E.
    Impera, S.
    Salvi, F.
    Spiriti, M.
    Marino, A.
    Roda, F.
    Alati, C.
    Ronco, F.
    Raimondo, F.
    Leoni, P.
    Alimena, G.
    Fioritoni, G.
    Latagliata, R.
    Nobile, F.
    HAEMATOLOGICA, 2013, 98 : 456 - 456
  • [44] An Integrated Analysis of Darbepoetin Alfa (DAR) in the Treatment of Anemia in Patients with Low- or Intermediate-1 (int-1) Risk Myelodysplastic Syndrome (MDS)
    Platzbecker, Uwe
    Symeonidis, Argiris
    Goede, Jeroen Simon
    Guerci-Bresler, Agnes
    Delforge, Michel
    Oliva, Esther Natalie
    Mayer, Jiri
    Badre, Sejal
    Mehta, Bhakti
    Brandao, Cisio De Oliveira
    BLOOD, 2017, 130
  • [45] Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients
    Platzbecker, U.
    Al-Ali, H. K.
    Gattermann, N.
    Haase, D.
    Janzen, V.
    Krauter, J.
    Goetze, K.
    Schlenk, R.
    Nolte, F.
    Letsch, A.
    Ottmann, O. G.
    Kuendgen, A.
    Luebbert, M.
    Germing, U.
    Wermke, M.
    Reinhard, H.
    Weiss, C.
    Lieder, K.
    Ehninger, G.
    Leismann, O.
    Giagounidis, A.
    LEUKEMIA, 2014, 28 (03) : 696 - 698
  • [46] Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry
    De Swart, Louise
    Reiniers, Chloe
    Bagguley, Tim
    Bowen, David
    Cermak, Jaroslav
    Hellstrom-Lindberg, Eva
    Tatic, Aurelia
    Symeonidis, Argiris
    Huls, Gerwin
    Panagiotidis, Panagiotis
    Garelius, Hege
    Culligan, Dominic
    Krejci, Marta
    van Marrewijk, Corine
    Droste, Jackie
    Smith, Alexandra
    Swinkels, Dorine W.
    de Witte, Theo
    BLOOD, 2015, 126 (23)
  • [47] Immunosuppressive treatment is associated with durable responses and a survival advantage in younger patients with int-1 myelodysplastic syndrome.
    Sloand, EM
    Greenberg, P
    Wu, C
    Young, NS
    Barrett, J
    BLOOD, 2005, 106 (11) : 707A - 707A
  • [48] Efficacy and Safety of Imetelstat in RBC Transfusion-Dependent (TD) IPSS Low/Int-1 MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents (ESA) (IMerge)
    Fenaux, Pierre
    Raza, Azra
    Vellenga, Edo
    Platzbecker, Uwe
    Santini, Valeria
    Samarina, Irina
    Van Eygen, Koen
    Diez-Campelo, Maria
    Patnaik, Mrinal M.
    Sherman, Laurie
    Sun, Libo
    Varsos, Helen
    Rose, Esther
    Rizo, Aleksandra
    Steensma, David P.
    BLOOD, 2017, 130
  • [49] The Revised IPSS (IPSS-R) Predicts Response To Erythropoietic Stimulating agents (ESA) In Pts With Classical IPSS Low Or Intermediate-1 (int 1)- MDS: A Joint Retrospective Study Of The GFM, Dusseldorf Registry and Fism
    Santini, Valeria
    Schemenau, Jennifer
    Levis, Alessandro
    Balleari, Enrico
    Sapena, Rosa
    Ades, Lionel
    Guerci, Agnes
    Beyne-Rauzy, Odile
    Gourin, Marie Pierre
    Cheze, Stephane
    Stamatoullas, Aspasia
    Sanna, Alessandro
    Gioia, Daniela
    Cametti, Giani
    Ferrero, Dario
    Raffoux, Emmanuel
    Rose, Christian
    Antonella, Poloni
    Prebet, Thomas
    Ame, Shanti
    Legros, Laurence
    Fenaux, Pierre
    Germing, Ulrich
    Dreyfus, Francois
    Park, Sophie
    BLOOD, 2013, 122 (21)
  • [50] Validation Of The Revised International Prognostic Scoring System (IPSS-R) In 1000 Newly Diagnosed MDS Patients With Low- and Intermediate-1 Risk MDS In The European Leukemianet MDS (EUMDS) Registry
    de Swart, Louise
    Smith, Alex
    Johnston, Tom
    Haase, Detlef
    Droste, Jackie
    Fenaux, Pierre
    Symeonidis, Argiris
    Sanz, Guillermo
    Hellstroem-Lindberg, Eva
    Cermak, Jaroslav
    Germing, Ulrich
    Stauder, Reinhard
    Georgescu, Otilia
    MacKenzie, Marius
    Malcovati, Luca
    Holm, Mette Skov
    Almeida, Antonio Medina
    Madry, Krzysztof
    Slama, Borhane
    Guerci-Bresler, Agnes
    Sanhes, Laurence
    Beyne-Rauzy, Odile
    Luno, Elisa
    Bowen, David
    de Witte, Theo
    BLOOD, 2013, 122 (21)
12345